Verizon Communications helped lead the way and rose 4%. The telecom giant reported a stronger profit for the latest quarter ...

Sarepta stock has tanked. Most investors don’t see the drugmaker’s executive management as credible following the failure to disclose a patient death, a BMO survey suggests.

What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the morning session after ...

Charles Schwab has expanded the list of securities available on its thinkorswim platform for overnight trading.

Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) plunged 10% after the company disclosed that the U.S. Food and Drug ...

Sarepta Therapeutics, Inc. faces setbacks with Elevidys, safety issues, and workforce cuts, raising concerns about its ...

On March 18, 2025, Sarepta announced that a patient that had been treated with Elevidys died after suffering acute liver failure. On this news, the price of Sarepta stock fell $27.81 per share, or ...

What Analysts Are Saying About Sarepta Therapeutics 5 market experts have recently issued ratings for this stock, with a consensus target price of $52.0. Turn $1000 into $1270 in just 20 days?